Novel Coronavirus (SARS-CoV-2/COVID-19)
FDA revised its April 3 emergency use authorization for N95 and similar respirators made in China to remove certain respirators that failed to demonstrate at least 95% particulate filtration efficiency when tested by the National Institute for Occupational Safety and Health.
The Food and Drug Administration issued an emergency use authorization to Rutgers Clinical Genomics Laboratory for the first COVID-19 diagnostic test with the option of using home-collected saliva samples.
CMS recently issued new Frequently Asked Questions to aid the Medicaid program and Children's Health Insurance Program in their response to the COVID-19 pandemic.
AHA urged the Federal Communications Commission to grant expedited approval to its request that the agency extend the COVID-19 Telehealth Program to all hospitals and other direct patient care facilities, regardless of their size, location, or for-profit or not-for-profit status.
The Centers for Medicare & Medicaid Services recently issued new Frequently Asked Questions to aid the Medicaid program and Children’s Health Insurance Program in their response to the COVID-19 pandemic.
Dear Chairman Pai:
Over the past few weeks, we’ve been talking about the “triple whammy” of issues related to COVID-19 that are contributing to an unprecedented financial crisis for hospitals and health systems.
This edition of Hacking Healthcare includes an examination of how COVID-19 led the United Kingdom’s (UK) National Health Service (NHS) to give the country’s intelligence and security agency emergency powers over its networks.
The Department of Health and Human Services has extended the deadline for health care providers to attest to receipt of payments from the Public Health and Social Services Emergency and accept the terms and conditions.